SCL
Stepan CoPrice & Indicators
TL;DR.
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders BuyIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Specialty Products volume growth | 30% | Q1 2026 | — |
| adjusted EPS non-GAAP | 45 | Q1 2026 call | — |
| adjusted net income non-GAAP | $10.3M | Q1 2026 call | — |
| cash dividend per share | 39.5 | Q1 2026 call | — |
| dividends paid | $8.9M | Q1 2026 call | — |
| leverage ratio | 2.7 | Q1 2026 call | — |
| net debt | $511M | Q1 2026 call | — |
| organic net sales growth | 4% | Q1 2026 call | — |
| polymer adjusted EBITDA growth non-GAAP | 8% | Q1 2026 call | — |
| polymer foreign currency translation impact on sales | 3% | Q1 2026 call | — |
| polymer North America volume growth | 5% | Q1 2026 call | — |
| polymer volume decline | -6% | Q1 2026 call | — |
| specialty products net sales growth | 24% | Q1 2026 call | — |
| surfactants organic net sales growth | 8% | Q1 2026 call | — |
| surfactants organic volume growth | 2% | Q1 2026 call | — |
| surfactants selling price growth | 2% | Q1 2026 call | — |
| Global sales volume | 1% | Twelve Months Ended December 31 | — |
| Global sales volume, excluding the impact of the Philippines asset divestiture | 2% | Twelve Months Ended December 31 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Specialty Chemicals — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
SCL
this stock
Stepan Co
|
$1.35B | +24.8% | -16.1% | — | 2.8% |
|
LIN
Linde PLC
|
$240.89B | +21.0% | +3.0% | 34.5 | 1.4% |
|
AIQUF
L Air Liquide SA /Fi
|
$125.91B | +7.6% | — | — | 0.0% |
|
SHW
Sherwin Williams Co
|
$83.40B | +3.0% | +26.4% | 32.5 | 3.2% |
|
ECL
Ecolab Inc.
|
$77.60B | +3.2% | +2.2% | 37.3 | 1.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| SCL | +6.1% | +7.7% | +10.9% | +5.2% | +24.8% |
| SPY | +1.3% | -0.2% | +10.1% | +1.1% | +10.7% |
| vs SPY | +4.8% | +7.9% | +0.8% | +4.2% | +14.1% |
Capital returns
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.